2 enrolling by invitation. .
Follow NAV4694: new trials by email Literature Review of NAV4694 trials Research Report on NAV4694
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alzheimer's Plasma Extension NAV4694 - Preclinical Alzheimer's Disease, Alzheimer's Disease (AD) | Enrolling by invitation | University of Southern California | 3000 | 2023-09-21 | 2026-08-18 | |
| Alzheimer's Disease Neuroimaging Initiative 4 Neuraceq, Amyvid, Tauvid - Mild Cognitive Impairment, Alzheimer Disease | Enrolling by invitation | University of Southern California | 1500 | 2023-06-09 | 2026-09-29 |
Alzheimer Disease (2) · Cognitive Dysfunction (2) · Plaque, Amyloid (2) · Cognition Disorders (1) · Dementia (1) · Pick Disease of the Brain (1)
University of Southern California (2)
United States (2) · Canada (1)
Paul Aisen, MD (2) · Michael Weiner, MD (1) · Reisa Sperling, MD (1) · Ronald Petersen, MD, PHD (1)
R01AG054029 (1), U19AG024904 (1)